Related Tags >> Avastin FDA Lucentis Biogen Idec

Genentech News

Most Popular Genentech Story

Genentech forges $350M deal for Bayhill diabetes program

June 10, 2009 — 10:03am ET | By John Carroll

San Mateo, CA-based Bayhill Therapeutics is pocketing a $25 million upfront fee and stands to gain up to $325 million in milestones from a new licensing deal with Genentech covering its early-stage... Read more...

Genentech Press Releases

FDA Advisory Committee Unanimously Recommends Accelerated Approval of Genentech's Avastin for Previously Treated Brain Cancer
FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market
Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market
Herceptin now shown to significantly prolong the lives of patients with HER2-positive advanced stomach cancer
Genentech Urges Stockholders to Take No Action With Respect to Revised Offer From Roche

Latest Headlines

Former Genentech CFO heads to Facebook
June 30, 2009
Arbitrator sides with Biogen in Rituxan dispute
June 17, 2009
Genentech forges $350M deal for Bayhill diabetes program
June 10, 2009
Agios recruits Genentech cancer star as new CEO
May 27, 2009
Roche readies cancer data for ASCO
May 19, 2009
Roche dealt setback as Avastin misses trial goal
April 22, 2009
Roche gets closer look at Genentech's R&D secrets
April 17, 2009
Genentech execs hit the door as Roche takes over
April 15, 2009
Roche seals Genentech takeover
March 26, 2009
Genentech's newly-rich scientists could pose a challenge
March 17, 2009
Roche combining trial groups after Genentech merger
March 16, 2009
Roche seals deal for Genentech at $95 a share
March 12, 2009
Report: Genentech and Roche near $46.7B deal
March 10, 2009
Roche ups bid for Genentech to $93 a share
March 6, 2009
ImmunoGen pockets $6.5M milestone
March 3, 2009
Genentech shows off its pipeline prospects
March 2, 2009
Roche stockpiles cash
February 27, 2009
Analysts plot strategy as Genentech rejects Roche
February 24, 2009
Roche raises $16B for Genentech bid
February 19, 2009
Roche confident of Genentech success
February 4, 2009

Paid Research Reports

More Research Reports >>